These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25649656)

  • 1. Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease.
    Casamenti F; Grossi C; Rigacci S; Pantano D; Luccarini I; Stefani M
    J Alzheimers Dis; 2015; 45(3):679-88. PubMed ID: 25649656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Therapeutic Effects of Oleuropein Aglycone in Alzheimer's Disease.
    Martorell M; Forman K; Castro N; Capó X; Tejada S; Sureda A
    Curr Pharm Biotechnol; 2016; 17(11):994-1001. PubMed ID: 27455905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates.
    Luccarini I; Grossi C; Rigacci S; Coppi E; Pugliese AM; Pantano D; la Marca G; Ed Dami T; Berti A; Stefani M; Casamenti F
    Neurobiol Aging; 2015 Feb; 36(2):648-63. PubMed ID: 25293421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain.
    Luccarini I; Ed Dami T; Grossi C; Rigacci S; Stefani M; Casamenti F
    Neurosci Lett; 2014 Jan; 558():67-72. PubMed ID: 24211687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon.
    Rigacci S; Guidotti V; Bucciantini M; Nichino D; Relini A; Berti A; Stefani M
    Curr Alzheimer Res; 2011 Dec; 8(8):841-52. PubMed ID: 21592051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology.
    Pantano D; Luccarini I; Nardiello P; Servili M; Stefani M; Casamenti F
    Br J Clin Pharmacol; 2017 Jan; 83(1):54-62. PubMed ID: 27131215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit.
    Diomede L; Rigacci S; Romeo M; Stefani M; Salmona M
    PLoS One; 2013; 8(3):e58893. PubMed ID: 23520540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology.
    Grossi C; Rigacci S; Ambrosini S; Ed Dami T; Luccarini I; Traini C; Failli P; Berti A; Casamenti F; Stefani M
    PLoS One; 2013; 8(8):e71702. PubMed ID: 23951225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy.
    Cordero JG; García-Escudero R; Avila J; Gargini R; García-Escudero V
    Oxid Med Cell Longev; 2018; 2018():5010741. PubMed ID: 29675133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olive Biophenols Reduces Alzheimer's Pathology in SH-SY5Y Cells and APPswe Mice.
    Omar SH; Scott CJ; Hamlin AS; Obied HK
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30598025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer's Disease.
    Rigacci S
    Adv Exp Med Biol; 2015; 863():1-20. PubMed ID: 26092624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employing Alzheimer disease animal models for translational research: focus on dietary components.
    Grossi C; Ed Dami T; Rigacci S; Stefani M; Luccarini I; Casamenti F
    Neurodegener Dis; 2014; 13(2-3):131-4. PubMed ID: 24192327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.